TIDMHEMO

RNS Number : 2057N

Hemogenyx Pharmaceuticals PLC

18 May 2020

Hemogenyx Pharmaceuticals plc

("Hemogenyx" or the "Company")

Exercise of Warrants

Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that, pursuant to the receipt of a warrant exercise notice, it has issued and allotted 668,000 ordinary shares of 1p each in the Company at an exercise price of 5.25p per share for a total consideration of GBP35,070.

Application will be made for the new Ordinary Shares to be admitted to trading on the Official List of the UK Listing Authority by way of a Standard Listing ('Admission'). The Shares will rank pari passu in all respects with the existing shares. Admission is expected to occur on or around 22 May 2020.

Total Voting Rights

Following Admission, the Company will have 397,921,969 ordinary shares of GBP0.01 each in issue with voting rights. This figure may then be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

Enquiries:

 
 Hemogenyx Pharmaceuticals plc           https://hemogenyx.com 
 Dr Vladislav Sandler, Chief Executive 
  Officer & Co-Founder                   headquarters@hemogenyx.com 
 Peter Redmond, Non-Executive Director 
 
                                         Tel: +44 (0)20 3470 
 SP Angel Corporate Finance LLP           0470 
 Matthew Johnson, Vadim Alexandre, 
  Soltan Tagiev

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOEUWVKRRSUVARR

(END) Dow Jones Newswires

May 18, 2020 05:56 ET (09:56 GMT)

Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Hemogenyx Pharmaceuticals Charts.
Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Hemogenyx Pharmaceuticals Charts.